SOUTHWEST ONCOLOGY GROUP CA-13612

西南肿瘤学组 CA-13612

• 批准号: 6341814
• 负责人: THOMAS Patrick MILLER
• 金额: $ 42.29万
• 依托单位: UNIVERSITY OF ARIZONA
• 依托单位国家: 美国
• 财政年份: 1978
• 资助国家: 美国
• 起止时间: 1978-01-01 至 2003-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6341814
• 关键词: antineoplastics; bleomycin; bone marrow transplantation; brain neoplasms; breast neoplasms; cancer information system; cancer prevention; cancer registry /resource; cis platinum compound; clinical research; clinical trials; combination cancer therapy; combination chemotherapy; cooperative study; cyclophosphamide; doxorubicin; drug resistance; female reproductive system neoplasm; fludarabine; gastrointestinal neoplasms; head /neck neoplasm; hormone therapy; human subject; human therapy evaluation; ifosfamide; leukemia; lung neoplasms; lymphoma; meeting /conference /symposium; melanoma; multiple myeloma; neoplasm /cancer chemotherapy; neoplasm /cancer diagnosis; neoplasm /cancer epidemiology; neoplasm /cancer genetics; neoplasm /cancer immunotherapy; neoplasm /cancer radiation therapy; neoplasm /cancer surgery; oncology nursing; paclitaxel; pancreas neoplasms; pathology; prognosis; prostate neoplasms; quality of life; sarcoma; tamoxifen; tissue resource /registry; urinary tract neoplasms; women's health

Description: Funding is requested to support the Arizona Cancer Center (University of Arizona) participation in Southwest Oncology Group cooperative cancer clinical research to improve the treatment of cancer in humans. Specific aims and objectives are: 1. To continue to meet current scientific leadership and core service commitments including: (A) protocol coordination (multiple studies); (B) disease/discipline committee administration; (C) reference and repository laboratory administration; and (D) group quality assurance and quality control. 2. To continue to promote the rapid integration of promising new research leads, including those developed at the Arizona Cancer Center, into cooperative group testing to improve patient treatment options and patient care. 3. To continue to meet institutional clinical research commitments in the recruitment of appropriate patients for SWOG studies and all attendant commitments to long-term follow up, quality control, etc. 4. To continue to promote community physician and patient awareness and participation in SWOG clinical trials by continued support of the Cooperative Group Outreach Program (CGOP) and other outreach and continuing education programs and activities. 5. To continue efforts to understand factors affecting accrual, particularly those in special populations (e.g., minority, elderly, financially disadvantaged), and to implement appropriate interventions where possible.

描述：申请资金支持亚利桑那癌症中心